Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic
  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Stonegate Healthcare Reviews Retinitis Pigmentosa

By: Newsfile

Dallas, Texas--(Newsfile Corp. - December 14, 2022) - Stonegate Healthcare has published a new report on Retinitis Pigmentosa (RP) and the pipeline of products in development. The report follows a recent webinar with ophthalmology experts, including a leading researcher and physician, Christine Kay, M.D., Vitreoretinal surgeon and IRD specialist at Vitreoretinal Associates, Eric Daniels, M.D., Chief Development Officer of Kiora Pharmaceuticals (NASDAQ: KPRX) and Ben Shaberman from the Foundation Fighting Blindness.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Retinitis Pigmentosa (RP) is the leading cause of visual disability and blindness in patients under 60.
  • Gene therapies, while promising, are limited in their application by disease stage and genetic mutation.
  • Small molecule photoswitches conversely hold potential to treat mid- to late-stage RP as a stand-alone drug or in combination with gene therapies.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/147987_stonegate1.jpg

Click image above to view full announcement.


Stonegate Capital Partners 

Stonegate Capital Partners is a leading advisory firm founded in 1972. We specialize in capital markets advisory with a focus on institutional investor outreach for public and private companies. Our affiliate, Stonegate Capital Markets (Member FINRA/SIPC) provides a full spectrum of investment banking services and equity research.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/147987

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.